Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAPHNE: Duodopa in Advanced Parkinson's Disease
NCT00141518Phase 4Completed
- Sponsor
- AbbVie Inc.
- Start
- Mar 2006
- Primary completion
- Mar 2011
- Modality
- Small Molecules
01
Overview
Phase 4, open-label trial of levodopa in Parkinson's disease (PD) (3 arms), sponsored by AbbVie Inc. Primary endpoints: Unified Parkinson's Disease Rating Scale Total Score at Month 12, Unified Parkinson's Disease Rating Scale Subscores I, II, III, and IV at Month 12 and 7 more. Started Mar 2006; status: completed.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00141518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00141518.